Formulation: A neat solid

Purity: ≥98%

Schedule: II

Formulation: A 1 mg/ml solution in methanol

• BAY-1470

Formulation: A neat solid

Purity: ≥98%

Schedule: III

• (R)-(+)-Ketamine

Formulation: A neat solid

Purity: ≥98%

• 2'-oxo-PCM
• deschloro-N-methyl-Ketamine
• O-PCM

Formulation: A 1 mg/ml solution in methanol

Formulation: A 1 mg/ml solution in methanol

• p-hydroxy Xylazine
• para-hydroxy Xylazine

Formulation: A solid

Purity: ≥99% (deuterated forms d₁-d₆)

Formulation: A neat solid

Purity: ≥98%

Schedule: III

• CI-581
• CL 369

Formulation: A neat solid

Purity: ≥98%

Schedule: III

• Esketamine
• (S)-(+)-Ketamine

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₄)

Schedule: III

Formulation: A crystalline solid

Purity: ≥98%

• BAY-1470

Formulation: A crystalline solid

Purity: ≥98%

• NSC 40030

Formulation: A crystalline solid

Purity: ≥98%

• CI-634
• CL-399
• CN 54521-2
• NSC 167740

Formulation: A 1 mg/ml solution in methanol

• CI-581
• CL 369

Formulation: A crystalline solid

Purity: ≥98%

• (+)-Etomidate
• d-Etomidate
• (R)-Etomidate
• R 16659

Formulation: A crystalline solid

Purity: ≥98%

Schedule: III

• (R)-(+)-Ketamine

Formulation: A solid

Purity: ≥98%

Schedule: III

• CI-581
• CL 369

Formulation: A 1 mg/ml solution in methanol

• (+)-Etomidate
• d-Etomidate
• (R)-Etomidate
• R 16659

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₆)

• p-hydroxy Xylazine-d₆
• para-hydroxy Xylazine-d₆

Formulation: A neat solid

Purity: ≥98%

Schedule: II

Formulation: A neat solid

Purity: ≥98%

• 3-methoxy-2-oxo PCM
• MMXE
• MXM

Formulation: A 10 mg/ml solution in acetonitrile

Purity: ≥98%

• (+)-Isopropoxate
• (R)-Isopropoxate

Formulation: A crystalline solid

Purity: ≥98%

• Novocaine

Formulation: A 10 mg/ml solution in acetonitrile

Purity: ≥98%

• (+)-R 7464
• (R)-Propoxate